Compromised trabecular microarchitecture and lower finite element estimates of radius and tibia bone strength in adults with turner syndrome: A cross-sectional study using high-resolution-pQCT

Journal of Bone and Mineral Research

Volumn 27, Issue 8, 2012, Pages 1794-1803

  Hansen, Stinus ^a   Brixen, Kim ^a   Gravholt, Claus H ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

BONE MICROARCHITECTURE; BONE STRENGTH; FINITE ELEMENT ANALYSIS; HR PQCT; TURNER SYNDROME

Indexed keywords

ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BONE CHARACTERISTICS AND FUNCTIONS; BONE DENSITY; BONE GEOMETRY; BONE MICROARCHITECTURE; BONE STRENGTH; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FINITE ELEMENT ANALYSIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; POROSITY; RADIUS; TIBIA; TIBIA FRACTURE; TRABECULAR BONE; TURNER SYNDROME;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; ADULT; ANTHROPOMETRY; BONE DENSITY; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FINITE ELEMENT ANALYSIS; HUMANS; MIDDLE AGED; RADIUS; REGRESSION ANALYSIS; TIBIA; TOMOGRAPHY, X-RAY COMPUTED; TURNER SYNDROME; YOUNG ADULT;

EID: 84864118915     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1624     Document Type: Article

References (45)

1. Rao E, Weiss B, Fukami M, Rump A, Niesler B, Mertz A, Muroya K, Binder G, Kirsch S, Winkelmann M, Nordsiek G, Heinrich U, Breuning MH, Ranke MB, Rosenthal A, Ogata T, Rappold GA., Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet. 1997 May; 16 (1): 54-63.
2. Marchini A, Hacker B, Marttila T, Hesse V, Emons J, Weiss B, Karperien M, Rappold G., BNP is a transcriptional target of the short stature homeobox gene SHOX. Hum Mol Genet. 2007; Dec 15; 16 (24): 3081-7.
3. Ogata T, Matsuo N, Nishimura G., SHOX haploinsufficiency and overdosage: impact of gonadal function status. J Med Genet. 2001 Jan; 38 (1): 1-6.
4. Sabherwal N, Blaschke RJ, Marchini A, Heine-Suner D, Rosell J, Ferragut J, Blum WF, Rappold G., A novel point mutation A170P in the SHOX gene defines impaired nuclear translocation as a molecular cause for Leri-Weill dyschondrosteosis and Langer dysplasia. J Med Genet. 2004 Jun; 41 (6): e83.
5. Chen J, Wildhardt G, Zhong Z, Roth R, Weiss B, Steinberger D, Decker J, Blum WF, Rappold G., Enhancer deletions of the SHOX gene as a frequent cause of short stature: the essential role of a 250 kb downstream regulatory domain. J Med Genet. 2009 Dec; 46 (12): 834-9.
6. Huber C, Rosilio M, Munnich A, Cormier-Daire V., High incidence of SHOX anomalies in individuals with short stature. J Med Genet. 2006 Sep; 43 (9): 735-9.
7. Bakalov VK, Chen ML, Baron J, Hanton LB, Reynolds JC, Stratakis CA, Axelrod LE, Bondy CA., Bone mineral density and fractures in Turner syndrome. Am J Med. 2003 Sep; 115 (4): 259-64.
8. Gravholt CH, Lauridsen AL, Brixen K, Mosekilde L, Heickendorff L, Christiansen JS., Marked disproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult turner syndrome: a cross-sectional study. J Clin Endocrinol Metab. 2002 Jun; 87 (6): 2798-808.
9. Lanes R, Gunczler P, Esaa S, Martinis R, Villaroel O, Weisinger JR., Decreased bone mass despite long-term estrogen replacement therapy in young women with Turner's syndrome and previously normal bone density. Fertil Steril. 1999 Nov; 72 (5): 896-9.
10. Gravholt CH, Juul S, Naeraa RW, Hansen J., Morbidity in Turner syndrome. J Clin Epidemiol. 1998; Feb; 51 (2): 147-58.
11. Gravholt CH, Vestergaard P, Hermann AP, Mosekilde L, Brixen K, Christiansen JS., Increased fracture rates in Turner's syndrome: a nationwide questionnaire survey. Clin Endocrinol (Oxf). 2003 Jul; 59 (1): 89-96.
12. Bondy CA, Ceniceros I, Lange E, Bakalov VK., Declining estrogen use in young women with Turner syndrome. Arch Intern Med. 2006 Jun 26; 166 (12): 1322.
13. Han TS, Cadge B, Conway GS., Hearing impairment and low bone mineral density increase the risk of bone fractures in women with Turner's syndrome. Clin Endocrinol (Oxf). 2006 Nov; 65 (5): 643-7.
14. Pors NS, Kolthoff N, Barenholdt O, Kristensen B, Abrahamsen B, Hermann AP, Brot C., Diagnosis of osteoporosis by planar bone densitometry: can body size be disregarded?. Br J Radiol. 1998 Sep; 71 (849): 934-43.
15. Neely EK, Marcus R, Rosenfeld RG, Bachrach LK., Turner syndrome adolescents receiving growth hormone are not osteopenic. J Clin Endocrinol Metab. 1993; Apr; 76 (4): 861-6.
16. Shaw NJ, Rehan VK, Husain S, Marshall T, Smith CS., Bone mineral density in Turner's syndrome-a longitudinal study. Clin Endocrinol (Oxf). 1997 Sep; 47 (3): 367-70.
17. Nissen N, Gravholt CH, Abrahamsen B, Hauge EM, Jensen JE, Mosekilde L, Brixen K., Disproportional geometry of the proximal femur in patients with Turner syndrome: a cross-sectional study. Clin Endocrinol (Oxf). 2007; Dec; 67 (6): 897-903.
18. Holroyd CR, Davies JH, Taylor P, Jameson K, Rivett C, Cooper C, Dennison EM., Reduced cortical bone density with normal trabecular bone density in girls with Turner syndrome. Osteoporos Int. 2010 Dec; 21 (12): 2093-9.
19. Bechtold S, Rauch F, Noelle V, Donhauser S, Neu CM, Schoenau E, Schwarz HP., Musculoskeletal analyses of the forearm in young women with Turner syndrome: a study using peripheral quantitative computed tomography. J Clin Endocrinol Metab. 2001 Dec; 86 (12): 5819-23.
20. Soucek O, Lebl J, Snajderova M, Kolouskova S, Rocek M, Hlavka Z, Cinek O, Rittweger J, Sumnik Z., Bone geometry and volumetric bone mineral density in girls with Turner syndrome of different pubertal stages. Clin Endocrinol (Oxf). 2011 Apr; 74 (4): 445-52.
21. Boutroy S, Bouxsein ML, Munoz F, Delmas PD., In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab. 2005 Dec; 90 (12): 6508-15.
22. Pistoia W, van Rietbergen B, Lochmuller EM, Lill CA, Eckstein F, Rüegsegger P., Image-based micro-finite-element modeling for improved distal radius strength diagnosis: moving from bench to bedside. J Clin Densitom. 2004; 7 (2): 153-60.
23. Hanson J., Standardization of femur BMD. J Bone Miner Res. 1997 Aug; 12 (8): 1316-7.
24. Laib A, Hildebrand T, Häuselmann HJ, Rüegsegger P., Ridge number density: a new parameter for in vivo bone structure analysis. Bone. 1997; Dec; 21 (6): 541-6.
25. Burghardt AJ, Kazakia GJ, Ramachandran S, Link TM, Majumdar S., Age- and gender-related differences in the geometric properties and biomechanical significance of intracortical porosity in the distal radius and tibia. J Bone Miner Res. 2010 May; 25 (5): 983-93.
26. Nishiyama KK, Macdonald HM, Buie HR, Hanley DA, Boyd SK., Postmenopausal women with osteopenia have higher cortical porosity and thinner cortices at the distal radius and tibia than women with normal aBMD: an in vivo HR-pQCT study. J Bone Miner Res. 2010 Apr; 25 (4): 882-90.
27. Pistoia W, van Rietbergen B, Lochmuller EM, Lill CA, Eckstein F, Rüegsegger P., Estimation of distal radius failure load with micro-finite element analysis models based on three-dimensional peripheral quantitative computed tomography images. Bone. 2002 Jun; 30 (6): 842-8.
28. Chiu J, Robinovitch SN., Prediction of upper extremity impact forces during falls on the outstretched hand. J Biomech. 1998 Dec; 31 (12): 1169-76.
29. Melton LJ III, Riggs BL, van Lenthe GH, Achenbach SJ, Muller R, Bouxsein ML, Amin S, Atkinson EJ, Khosla S., Contribution of in vivo structural measurements and load/strength ratios to the determination of forearm fracture risk in postmenopausal women. J Bone Miner Res. 2007; Sep; 22 (9): 1442-8.
30. Hansen S, Beck Jensen JE, Rasmussen L, Hauge EM, Brixen K., Effects on bone geometry, density, and microarchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: a case-control study using HR-pQCT. J Bone Miner Res. 2010 Sep; 25 (9): 1941-7.
31. Landin-Wilhelmsen K, Bryman I, Windh M, Wilhelmsen L., Osteoporosis and fractures in Turner syndrome-importance of growth promoting and oestrogen therapy. Clin Endocrinol (Oxf). 1999 Oct; 51 (4): 497-502.
32. Frost HM., The Utah paradigm of skeletal physiology: an overview of its insights for bone, cartilage and collagenous tissue organs. J Bone Miner Metab. 2000; 18 (6): 305-16.
33. Nishiyama KK, Macdonald HM, Moore SA, Fung T, Boyd SK, McKay HA., Cortical porosity is higher in boys compared with girls at the distal radius and distal tibia during pubertal growth: an HR-pQCT study. J Bone Miner Res. 2012 Feb; 27 (2): 273-82.
34. Wang Q, Alen M, Nicholson P, Lyytikainen A, Suuriniemi M, Helkala E, Suominen H, Cheng S., Growth patterns at distal radius and tibial shaft in pubertal girls: a 2-year longitudinal study. J Bone Miner Res. 2005 Jun; 20 (6): 954-61.
35. Bakalov VK, Axelrod L, Baron J, Hanton L, Nelson LM, Reynolds JC, Hill S, Troendle J, Bondy CA., Selective reduction in cortical bone mineral density in turner syndrome independent of ovarian hormone deficiency. J Clin Endocrinol Metab. 2003 Dec; 88 (12): 5717-22.
36. Hanton L, Axelrod L, Bakalov V, Bondy CA., The importance of estrogen replacement in young women with Turner syndrome. J Womens Health (Larchmt). 2003 Dec; 12 (10): 971-7.
37. Rauch F, Neu C, Manz F, Schoenau E., The development of metaphyseal cortex-implications for distal radius fractures during growth. J Bone Miner Res. 2001 Aug; 16 (8): 1547-55.
38. Schoenau E, Neu CM, Rauch F, Manz F., Gender-specific pubertal changes in volumetric cortical bone mineral density at the proximal radius. Bone. 2002 Jul; 31 (1): 110-3.
39. Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, van Teunenbroek A, van Leeuwen WJ, Asarfi A, van Rijn RR, Drop SL, Dutch Advisory Group on Growth Hormone. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study. Pediatr Res. 2001 Sep; 50 (3): 417-22.
40. Sato N, Nimura A, Horikawa R, Katumata N, Tanae A, Tanaka T., Bone mineral density in Turner syndrome: relation to GH treatment and estrogen treatment. Endocr J. 2000 Mar; 47 Suppl: S115-9.
41. Vanderschueren D, Venken K, Ophoff J, Bouillon R, Boonen S., Clinical Review: Sex steroids and the periosteum-reconsidering the roles of androgens and estrogens in periosteal expansion. J Clin Endocrinol Metab. 2006 Feb; 91 (2): 378-82.
42. Wang Q, Alen M, Nicholson PH, Halleen JM, Alatalo SL, Ohlsson C, Suominen H, Cheng S., Differential effects of sex hormones on peri- and endocortical bone surfaces in pubertal girls. J Clin Endocrinol Metab. 2006 Jan; 91 (1): 277-82.
43. Marchini A, Marttila T, Winter A, Caldeira S, Malanchi I, Blaschke RJ, Häcker B, Rao E, Karperien M, Wit JM, Richter W, Tommasino M, Rappold GA., The short stature homeodomain protein SHOX induces cellular growth arrest and apoptosis and is expressed in human growth plate chondrocytes. J Biol Chem. 2004 Aug 27; 279 (35): 37103-14.
44. Munns CF, Glass IA, LaBrom R, Hayes M, Flanagan S, Berry M, Hyland VJ, Batch JA, Philips GE, Vickers D., Histopathological analysis of Leri-Weill dyschondrosteosis: disordered growth plate. Hand Surg. 2001 Jul; 6 (1): 13-23.
45. Olsen BR, Reginato AM, Wang W., Bone development. Annu Rev Cell Dev Biol. 2000; 16: 191-220.